NIMI
PRAH

Natixis Investment Managers International’s PRA Health Sciences, Inc. PRAH Stock Holding History

Natixis Investment Managers International’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,305
Closed -$108K – 727
2018
Q1 		$108K Buy
+1,305
New +$116K 0.01% 408

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Natixis Investment Managers International's PRAH Position: Q2 2018 in Review

Natixis Investment Managers International sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2018, closing a stake of 1,305 shares — an estimated $108K sold.

Natixis Investment Managers International first reported a position in PRAH in Q1 2018 and held it in 1 quarter. The position peaked at $108K in Q1 2018. 300 funds tracked by Wall St. Rank hold PRAH as of Q2 2018.

  • Natixis Investment Managers International reported no remaining PRA Health Sciences, Inc. position as of Q2 2018 after selling out during the quarter.
  • Natixis Investment Managers International sold 1,305 PRA Health Sciences, Inc. shares in Q2 2018, an estimated $108K.
  • Natixis Investment Managers International first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 1 quarter.
  • Natixis Investment Managers International's PRA Health Sciences, Inc. position peaked at $108K in Q1 2018.
  • 300 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2018.

Based on Natixis Investment Managers International's 13F filing for Q2 2018, filed 14 Aug 2018.